Litcius/Paper detail

Elranatamab: First Approval

Sohita Dhillon

2023Drugs39 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMultiple myelomaCD38BortezomibInternal medicineOncologyClinical trialImmunologyStem cellCD34GeneticsBiologyCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research
Elranatamab: First Approval | Litcius